Guerra CE, Woo K, Heitjan DF. — University of Pennsylvania
Ross KM, Holmboe E, Lynn LA. — American Board of Internal Medicine
Kirkland D, Brooks D. — American Cancer Society
Presented: Society of General Internal Medicine Annual Meeting, April 2013
Colorectal cancer screening (CRCS) is effective, cost-effective and consistently recommended by clinical guidelines, yet only 64.5% of Americans aged 50–75 years have been screened. Recommendation from a physician is the most influential factor in determining whether a patient is screened for colorectal cancer. This study was undertaken to determine whether the Evidence-Based Toolbox and Guide to Increase Primary Care Clinicians' Rates of CRCS, developed by the Centers for Disease Control and Prevention and the American Cancer Society, could help diplomates of the American Board of Internal Medicine (ABIM) maintaining certification in internal medicine increase their practice rates of CRCS. The main study aim was to compare practice rates of CRCS in the control (PIM only) and study (PIM + toolbox) arms.
In this randomized controlled trial, diplomates who were primary care providers for patients over age 50 and who were enrolled in ABIM's Maintenance of Certification program were invited to participate. Participants had to enroll in the Cancer Screening Practice Improvement Module (PIM), which requires physician-directed measurement of their performance and design of a quality improvement plan. Diplomates were randomized to the PIM or the PIM + toolbox arm. The toolbox consisted of four essential sections and evidence-based tools: Your Recommendation, An Office-based Policy, a Reminder System and an Effective Communication System. Analysis was based on the intention-to-treat principle. An external auditor determined the validity of self-reported CRCS rates in a random sample of 20% of the participants.
A total of 2,288 recruitment e-mails were sent to ABIM diplomates who met the inclusion/exclusion criteria, of whom 160 diplomates expressed interest in participation and 144 enrolled in the study. Of these, 79 diplomates completed the study. The CRCS rates declined in 17 of the 79, but improved in the remaining 62. All final CRCS were adjusted for the baseline performance and all results showed a non-significant treatment effect. Medical school country was the only predictor of improved screening rates post-treatment. Physicians who attended medical school abroad had an odds ratio of 4.32 (95% CI: 1.75-10.65) of performing a successful screening compared to physicians who attended medical school in the U.S.
These results demonstrated that while most diplomates improved their CRCS rates from baseline during the study, the improvement was not significantly different in the control arm (PIM only) compared to the study arm (PIM + toolbox). Medical school country was the only predictor of success rate.
For more information about this presentation, please contact Research@abim.org